NCT05517707 is a clinical trial of Nasogastric Tube in Nasogastric Tube, sponsored by Gravitas Medical, Inc..

Who is sponsoring NCT05517707?

NCT05517707 is sponsored by Gravitas Medical, Inc..

What drugs are being tested in NCT05517707?

Interventions in NCT05517707: Nasogastric Tube.

What condition does NCT05517707 study?

NCT05517707 studies Nasogastric Tube.

Is NCT05517707 still recruiting?

NCT05517707 is currently completed. Last updated 14 September 2023.

Last reviewed 2023-09-14 · How we verify

NCT05517707

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gravitas Feeding Tube System Placement in Neonates

Completed Last updated 14 September 2023

What this trial tests

trial testing Nasogastric Tube in Nasogastric Tube in 16 participants. Completed in 29 August 2023.

Timeline

10 November 2022

Primary endpoint
29 August 2023

29 August 2023

Quick facts

Lead sponsor	Gravitas Medical, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	16
Start date	10 November 2022
Primary completion	29 August 2023
Estimated completion	29 August 2023
Sites	1 location across United States

Drugs / interventions tested

Nasogastric Tube

Conditions studied

Nasogastric Tube — all drugs for Nasogastric Tube →

Sponsor

Gravitas Medical, Inc.

Who can join

Adults 0 Weeks to 18 Weeks, any sex, with Nasogastric Tube. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to optimize the Gravitas Feeding Tube System Placement Algorithm for NICU patients and to evaluate the safety and effectiveness of the Gravitas Feeding Tube in the neonate population for the administration of nutrition, fluids and medications.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A novel neonatal feeding tube with real time placement guidance.
Rao A, Jain J, Green G, Sutaria S, et al · · 2025 · PMID 41034518 · DOI 10.1038/s41598-025-20821-0

Verify or expand the search:

Other recruiting trials for Nasogastric Tube

Currently open trials in the same condition.

NCT06262815 — The Utility of Treatment With Nasogastric Tube Placement for Small Bowel Obstruction · active not recruiting

Other Gravitas Medical, Inc. trials

Trials by the same sponsor.

NCT06660758 — Pilot Study of the Entarik System With Advanced Functionality in Health Adults · NA · recruiting
NCT05884216 — Entarik Feeding Tube System Placement in Adult ICU · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05517707 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gravitas Medical, Inc.
Last refreshed: 14 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05517707.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing